Goldman Sachs Group Inc Xencor Inc Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,017,453 shares of XNCR stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,017,453
Previous 716,392
42.02%
Holding current value
$15.2 Million
Previous $5.63 Million
111.97%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding XNCR
# of Institutions
220Shares Held
81.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$166 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.7MShares$159 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$106 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.22MShares$92.9 Million0.98% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$91.7 Million5.41% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $891M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...